Embedded Files
Creating a world without dementia
Despite decades of research,
most dementia treatments remain symptomatic,
with few disease-modifying therapies reaching patients.
Nanil leverages
custom-built AI models and
off-the-shelf organoid models
to streamline and optimize
the design of therapeutic biologics,
including antibodies and RNA-based drugs,
targeting key molecular drivers like tau.
By dramatically reducing
the time and cost
of early-stage drug development,
Nanil aims to shift the paradigm
from trial-and-error approaches
to precision-guided biologic innovation.
OUR TEAM
OUR TEAM
Beeni Raj, PhD
Beeni Raj, PhD
Based in Canada, Dr. Raj is a clinical neuropharmacologist with experience across several pharmaceutical companies. She holds a strong academic foundation from Harvard Medical School and the University of California, San Francisco. With deep expertise in biomarker and therapeutic development for neurodegenerative diseases, she integrates clinical insight with computational innovation to advance drug discovery.
Anuj Guruvacharya, PhD
Anuj Guruvacharya, PhD
Based in Canada, Dr. Guruvacharya is a computational biologist. With a strong background in AI-driven drug discovery and neurodegeneration research, he specializes in developing scalable models to decode complex biological data. His previous experiences include working for various biotech companies in Washington D.C., for the cloud computing division within Amazon, and for Gilbert Family Foundation. He has a doctorate from University of Oklahoma.
James Goldn, PhD
James Goldn, PhD
Based in San Francisco, Dr. Goldn has deep expertise in neural networks, computer vision, and natural language processing. With a strong academic foundation from Swarthmore, Cornell, and Stanford, James brings a unique interdisciplinary perspective to AI and machine learning. His latest job was at Amazon. Prior to joining Amazon, he conducted postdoctoral research in computational neuroscience and deep learning for medical imaging at UCSF and Stanford, contributing to both translational brain tumor research and vision science.
Ammasi Periasamy, PhD
Ammasi Periasamy, PhD
Based from Virginia, Dr. Periasamy is a Professor of Biology and Biomedical Engineering at the University of Virginia and the founding Director of the W.M. Keck Center for Cellular Imaging. An internationally recognized leader in advanced light microscopy, Dr. Periasamy pioneered the development of fluorescence lifetime imaging microscopy (FLIM) and FRET techniques for studying protein-protein interactions in living cells.
Page updated
Google Sites
Report abuse